Vladislav Sandler

Founder at HEMOGENYX PHARMACEUTICALS PLC

Net worth: 941 588 $ as of 2026-07-30

61 year

Health Technology

Consumer Services

Profile

Vladislav Sandler is the founder of HemoGenyx Pharmaceuticals Plc, founded in 2012, holding the title of Chief Executive Officer & Executive Director since 2017.
Dr. Sandler is also the founder of Hemogenyx Pharmaceuticals LLC..
Dr. Sandler currently holds the position of Director at Hemogenyx UK Ltd. since 2017.
Since 2019, Dr. Sandler has been Chief Executive & Scientific Officer at Immugenyx LLC.
Dr. Sandler is an Assistant Professor at the State University of New York at Downstate Medical Center.
Dr. Sandler is a Member of The International Society for Stem Cell Research.
Dr. Sandler earned a doctorate degree from the University of British Columbia.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
HEMOGENYX PHARMACEUTICALS PLC 1.67%	2025-12-30	113,861 ( 1.67% )	941 588 $	2026-07-30

Vladislav Sandler active positions

Companies	Position	Start
HEMOGENYX PHARMACEUTICALS PLC	Founder	2011-12-31
Hemogenyx Pharmaceuticals LLC Hemogenyx Pharmaceuticals LLC BiotechnologyHealth Technology Operates as biopharmaceutical company that develops treatment for blood diseases	Founder	-
State University of New York at Downstate Medical Center State University of New York at Downstate Medical Center Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-
The International Society for Stem Cell Research The International Society for Stem Cell Research The International Society for Stem Cell Research (ISSCR) is a nonprofit organization dedicated to advancing stem cell science and its applications to human health. The non-profit company is based in Deerfield, IL. It represents nearly 5,000 members from over 80 countries, including scientists, educators, ethicists, clinicians, and business leaders. ISSCR promotes rigorous and ethical research through the development of international guidelines and quality standards, and provides resources such as the open-access journal Stem Cell Reports, standards documents for human stem cell use, and educational programs including annual meetings, symposia, webinars, and on-demand scientific content. The society supports workforce development by engaging early career scientists and trainees, fosters collaboration through a directory of stem cell societies and institutes, and conducts advocacy and policy efforts to provide scientific input to regulatory agencies and combat unproven stem cell therapies. ISSCR emphasizes equity, diversity, and inclusion, and offers resources for researchers, clinicians, educators, patients, and policymakers. The organization facilitates access to funding opportunities, supports continuing education, and promotes public and patient education. Membership benefits include networking, reduced fees for meetings and publishing, and access to scientific content.	Corporate Officer/Principal	-
Hemogenyx UK Ltd. Hemogenyx UK Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals	Director/Board Member	2017-10-03
Immugenyx LLC Immugenyx LLC BiotechnologyHealth Technology Operates biotechnology company	Chief Executive Officer	2018-12-31

All active positions of Vladislav Sandler

Training of Vladislav Sandler

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Vladislav Sandler's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
University of British Columbia University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
State University of New York at Downstate Medical Center State University of New York at Downstate Medical Center Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The International Society for Stem Cell Research The International Society for Stem Cell Research The International Society for Stem Cell Research (ISSCR) is a nonprofit organization dedicated to advancing stem cell science and its applications to human health. The non-profit company is based in Deerfield, IL. It represents nearly 5,000 members from over 80 countries, including scientists, educators, ethicists, clinicians, and business leaders. ISSCR promotes rigorous and ethical research through the development of international guidelines and quality standards, and provides resources such as the open-access journal Stem Cell Reports, standards documents for human stem cell use, and educational programs including annual meetings, symposia, webinars, and on-demand scientific content. The society supports workforce development by engaging early career scientists and trainees, fosters collaboration through a directory of stem cell societies and institutes, and conducts advocacy and policy efforts to provide scientific input to regulatory agencies and combat unproven stem cell therapies. ISSCR emphasizes equity, diversity, and inclusion, and offers resources for researchers, clinicians, educators, patients, and policymakers. The organization facilitates access to funding opportunities, supports continuing education, and promotes public and patient education. Membership benefits include networking, reduced fees for meetings and publishing, and access to scientific content.
Hemogenyx Pharmaceuticals LLC Hemogenyx Pharmaceuticals LLC BiotechnologyHealth Technology Operates as biopharmaceutical company that develops treatment for blood diseases	Health Technology
HemoGenyx Pharmaceuticals Plc HemoGenyx Pharmaceuticals Plc BiotechnologyHealth Technology Operates as biopharmaceutical company that develops treatment for blood diseases	Health Technology
Hemogenyx UK Ltd. Hemogenyx UK Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals	Health Technology
Immugenyx LLC Immugenyx LLC BiotechnologyHealth Technology Operates biotechnology company	Health Technology